Abstract
Background and study aims Dedicated stents placed under endoscopic ultrasound (EUS) guidance have shown promise
for the management of pancreatic walled-off necrosis (WON). A long duration of stent
placement may increase the risk of adverse events. We prospectively evaluated the
effects of (i) early removal of biflanged metal stents (BFMSs) and (ii) additional
stenting of the pancreatic duct with plastic stents in patients with ductal leaks,
on the risk of WON recurrence.
Patients and methods Symptomatic patients with pancreatic WON underwent EUS-guided BFMS placement, followed
by necrosectomy, when required, from Day 3. A 5 Fr plastic stent was placed in patients
with ductal leak. BFMS was removed when the WON cavity had collapsed completely. Patients
were followed up at 3-month intervals.
Results BFMS placement was successful in all 88 patients. A total of 64 patients (72.7 %)
underwent necrosectomy (median 3 sessions). All BFMSs were removed at a median of
3.5 weeks (range 3 – 17 weeks). Ductal disconnection and leak occurred in 53/87 (60.9 %)
and 61/87 (70.1 %) patients, respectively. A 5 Fr stent was placed in 56/61 patients
(91.8 %) with ductal leak. Overall, 22 patients (25.0 %) had adverse events (17 mild,
1 moderate, 3 severe, 1 fatal). Recurrence was noted in 8/88 (9.1 %) at a median follow-up
of 22 months. The recurrence rate was higher in patients with ductal disconnection
than in those without (13.2 % vs. 2.9 %; P = 0.08), and was similar in patients with vs. without pancreatic duct stenting (7.1 %
vs. 12.9 %; P = 0.44). Seven recurrences (87.5 %) partially regressed on follow-up and did not
require therapy; in one case, drainage with a plastic stent was performed.
Conclusions Short-term BFMS placement is an effective therapy for pancreatic WON. The majority
of recurrences developed in patients with ductal disconnection and did not require
therapy. Additional pancreatic duct stents probably do not influence the recurrence
rate.